Groesbeck Investment Management’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-3,460
| Closed | -$204K | – | 68 |
|
|
2024
Q2 | $204K | Buy |
+3,460
| New | +$216K | 0.28% | 70 |
|
|
2023
Q2 | – | Sell |
-3,284
| Closed | -$244K | – | 84 |
|
|
2023
Q1 | $244K | Hold |
3,284
| – | – | 0.37% | 75 |
|
|
2022
Q4 | $306K | Hold |
3,284
| – | – | 0.51% | 63 |
|
|
2022
Q3 | $304K | Hold |
3,284
| – | – | 0.5% | 68 |
|
|
2022
Q2 | $304K | Sell |
3,284
-370
| -10% | -$36.1K | 0.5% | 68 |
|
|
2022
Q1 | $370K | Hold |
3,654
| – | – | 0.41% | 80 |
|
|
2021
Q4 | $377K | Hold |
3,654
| – | – | 0.48% | 65 |
|
|
2021
Q3 | $310K | Sell |
3,654
-1,876
| -34% | -$157K | 0.36% | 91 |
|
|
2021
Q2 | $461K | Buy |
5,530
+1,657
| +43% | +$136K | 0.59% | 65 |
|
|
2021
Q1 | $291K | Sell |
3,873
-1,100
| -22% | -$80.1K | 0.42% | 80 |
|
|
2020
Q4 | $340K | Buy |
4,973
+31
| +0.6% | +$2.02K | 0.56% | 64 |
|
|
2020
Q3 | $289K | Hold |
4,942
| – | – | 0.54% | 64 |
|
|
2020
Q2 | $321K | Sell |
4,942
-94
| -2% | -$5.92K | 0.64% | 63 |
|
|
2020
Q1 | $299K | Sell |
5,036
-36,069
| -88% | -$2.41M | 0.8% | 50 |
|
|
2019
Q4 | $3.05M | Sell |
41,105
-951
| -2% | -$66.8K | 2.26% | 12 |
|
|
2019
Q3 | $2.65M | Buy |
42,056
+29
| +0.1% | +$1.72K | 1.99% | 15 |
|
|
2019
Q2 | $2.29M | Sell |
42,027
-29
| -0.1% | -$1.56K | 1.86% | 19 |
|
|
2019
Q1 | $2.27M | Buy |
42,056
+237
| +0.6% | +$14.6K | 1.73% | 18 |
|
|
2018
Q4 | $2.74M | Sell |
41,819
-1,104
| -3% | -$82.4K | 2.34% | 14 |
|
|
2018
Q3 | $3.38M | Hold |
42,923
| – | – | 2.3% | 16 |
|
|
2018
Q2 | $2.76M | Buy |
42,923
+27,825
| +184% | +$1.83M | 1.93% | 22 |
|
|
2018
Q1 | $939K | Buy |
15,098
+760
| +5% | +$54.5K | 0.68% | 39 |
|
|
2017
Q4 | $1.04M | Sell |
14,338
-829
| -5% | -$60.3K | 0.73% | 37 |
|
|
2017
Q3 | $1.23M | Sell |
15,167
-203
| -1% | -$16.1K | 0.89% | 35 |
|
|
2017
Q2 | $1.24M | Sell |
15,370
-1,170
| -7% | -$92.4K | 0.92% | 34 |
|
|
2017
Q1 | $1.3M | Buy |
16,540
+233
| +1% | +$18.6K | 0.97% | 32 |
|
|
2016
Q4 | $1.29M | Buy |
16,307
+7,955
| +95% | +$644K | 1.01% | 33 |
|
|
2016
Q3 | $743K | Sell |
8,352
-6,723
| -45% | -$635K | 0.55% | 44 |
|
|
2016
Q2 | $1.44M | Buy |
15,075
+2,258
| +18% | +$225K | 1.05% | 33 |
|
|
2016
Q1 | $1.33M | Buy |
+12,817
| New | +$1.25M | 0.95% | 38 |
|
Other funds holding CVS
Groesbeck Investment Management's CVS Position: Q3 2024 in Review
Groesbeck Investment Management sold out of CVS Health (CVS) in Q3 2024, closing a stake of 3,460 shares — an estimated $204K sold.
Groesbeck Investment Management first reported a position in CVS in Q1 2016 and held it in 30 quarters. The position peaked at $3.38M in Q3 2018. 1,840 funds tracked by Wall St. Rank hold CVS as of Q3 2024.
- Groesbeck Investment Management reported no remaining CVS Health position as of Q3 2024 after selling out during the quarter.
- Groesbeck Investment Management sold 3,460 CVS Health shares in Q3 2024, an estimated $204K.
- Groesbeck Investment Management first reported a position in CVS Health in Q1 2016 and held it in 30 quarters.
- Groesbeck Investment Management's CVS Health position peaked at $3.38M in Q3 2018.
- 1,840 funds tracked by Wall St. Rank held CVS Health as of Q3 2024.
Based on Groesbeck Investment Management's 13F filing for Q3 2024, filed 23 Oct 2024.